Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

51.7K
Overview
51.7K
Cancer Vaccines01:30

Cancer Vaccines

1.1K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.1K
Tumor Progression02:07

Tumor Progression

7.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.4K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

280
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
280
Hepatic Portal System01:21

Hepatic Portal System

6.0K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
6.0K
Sustainable Development01:43

Sustainable Development

15.1K
As the human population continues to grow and use resources, we must be mindful of our planet’s natural limits. Sustainable development provides a pathway to maintain and improve human life now while also ensuring that future generations will have the resources that they need. The long-term success of sustainability efforts rests on understanding the interplay between human actions and ecological systems.
15.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

"That's not my silo": Navigating fragmented long COVID care in the mid-Atlantic United States.

SSM. Qualitative research in health·2026
Same author

Flowing differently: exploratory characterization of menstrual effluent compared with peripheral blood.

F&S science·2026
Same author

5' leader defects drive persistent HIV-1 viremia on long-term ART.

Nature communications·2026
Same author

Reply to Soliman et al, Rapid HCV diagnostics: aligning molecular innovation with real-world elimination needs.

The Journal of infectious diseases·2026
Same author

HIV causes global B cell dysregulation and restricts HBV-specific B cell development in an incident HBV cohort.

The Journal of clinical investigation·2026
Same author

Allograft and recipient tissue injury during cardiac allograft rejection: Evidence from cell-free DNA.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026

Related Experiment Video

Updated: Feb 4, 2026

Author Spotlight: Developing a Simple and Robust Hepatic Model for Pharmacological and Toxicological Applications
07:23

Author Spotlight: Developing a Simple and Robust Hepatic Model for Pharmacological and Toxicological Applications

Published on: October 20, 2023

1.9K

Approaches, Progress, and Challenges to Hepatitis C Vaccine Development.

Justin R Bailey1, Eleanor Barnes2, Andrea L Cox1

  • 1Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Gastroenterology
|October 1, 2018
PubMed
Summary

Developing a hepatitis C virus (HCV) vaccine is crucial for global control, despite challenges like virus diversity and limited testing models. An effective vaccine could prevent new infections and reduce the disease burden worldwide.

Keywords:
HCVProphylactic VaccinationVaccinesViral Hepatitis

More Related Videos

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

14.0K
Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.8K

Related Experiment Videos

Last Updated: Feb 4, 2026

Author Spotlight: Developing a Simple and Robust Hepatic Model for Pharmacological and Toxicological Applications
07:23

Author Spotlight: Developing a Simple and Robust Hepatic Model for Pharmacological and Toxicological Applications

Published on: October 20, 2023

1.9K
Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

14.0K
Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.8K

Area of Science:

  • Virology
  • Immunology
  • Vaccinology

Background:

  • Hepatitis C virus (HCV) infection presents a significant global health challenge, with 1.75 million new cases in 2015.
  • The World Health Organization targets a 90% reduction in new HCV infections by 2030, highlighting the need for effective interventions.

Purpose of the Study:

  • To review the necessity and challenges of developing a prophylactic hepatitis C virus (HCV) vaccine.
  • To explore vaccine strategies and their testing in various populations.

Main Methods:

  • Review of existing literature on HCV vaccine development, including tested strategies and barriers.
  • Analysis of immune responses and their potential role in viral clearance and prevention of chronic infection.

Main Results:

  • Several vaccine strategies, including adjuvant and viral vector-based approaches, have been tested, primarily in non-at-risk populations.
  • Viral vectors encoding nonstructural proteins represent the only strategy tested in at-risk individuals.

Conclusions:

  • A prophylactic HCV vaccine is essential for achieving global control of the virus.
  • Overcoming challenges related to virus diversity, testing models, and understanding protective immunity is critical for successful vaccine development.